Abstract Age remains the main risk factor for developing Alzheimer's disease (AD) although certain metabolic alterations, including prediabetes and type 2 diabetes (T2D), may also increase this risk. In order to understand this relationship, we have studied an AD-prediabetes mouse model (APP/PS1) with severe hyperinsulinemia induced by long-term high fat diet (HFD), and an AD-T2D model, generated by crossing APP/PS1 and db/db mice (APP/PS1xdb/db). In both, prediabetic and diabetic AD mice, we have analyzed underlying neuronal pathology and synaptic loss. At 26 weeks of age, when both pathologies were clearly established, we observed severe brain atrophy in APP/PS1xdb/db animals as well as cortical thinning, accompanied by increased caspase activity. Reduced senile plaque burden and elevated soluble Aβ40 and 42 levels were observed in AD-T2D mice. Further assessment revealed a significant increase of neurite curvature in prediabetic-AD mice, and this effect was worsened in AD-T2D animals. Synaptic density loss, analyzed by array tomography, revealed a synergistic effect between T2D and AD, whereas an intermediate state was observed, once more, in prediabetic-AD mice. Altogether, our data suggest that early prediabetic hyperinsulinemia may exacerbate AD pathology, and that fully established T2D clearly worsens these effects. Therefore, it is feasible that early detection of prediabetic state and strict metabolic control could slow or delay progression of AD-associated neuropathological features.
Background
Alzheimer's disease (AD) is the most common cause of dementia among elderly people and, at present, it has no successful treatment. Neuropathological features include senile plaques (SP), mainly composed of amyloid-β (Aβ), and neurofibrillary tangles, comprised of phosphorylated tau [1] . More than these classical lesions, synaptic loss and reduced expression of synaptic proteins are the strongest pathological correlate of dementia and have the potential to may be more reliable markers of the progression of AD [2, 3] .
Although age remains the main risk factor for AD, the ultimate causes are not completely understood. Epidemiological, clinical, and animal studies also support that prediabetes [4] [5] [6] and type 2 diabetes (T2D) [7] [8] [9] may also be influential risk factors to develop AD, and since prediabetes, although still reversible, goes largely undiagnosed in the population, it might be a critical control point. Previous studies have described links between T2D and AD which associate both pathologies. Among others, insulin receptors in the central nervous system are highly expressed in cognition-related regions, such as the cortex and the hippocampus, consistent with evidence showing that insulin levels influence memory [10] . Aβ oligomers, likely the most toxic Aβ species, may directly interfere with insulin signalling in hippocampal neurons resulting in memory dysfunction [11] . Aβ accumulation is currently seen as a key step in the pathogenesis of AD, [12] and insulin may regulate Aβ levels [13, 14] , as well as exacerbate inflammatory responses that promote pathological Aβ processing and deposition (for review see [15] [16] [17] ). Furthermore, reduced brain insulin signalling in mouse models of diabetes increases tau phosphorylation and Aβ levels [18, 19] . Nevertheless, the mechanisms underlying the relationship between diabetes and dementia have not been completely elucidated.
Recently, various transgenic animal models have been developed in order to further explore this relationship and derived consequences, including prediabetic and diabetic AD models [20, 21] . In the present study, we have used two animal models: (1) a prediabetic hyperinsulinemic AD mouse line, induced by long-term high fat diet (HFD) administration to APPswe/PS1dE9 mice (APP/PS1) [20] , and (2) a long-term type 2 diabetic AD mouse, by using a mixed model of AD (APP/PS1 mouse) and a T2D (db/db mouse) (APP/PS1xdb/ db) [19] . These mouse lines allowed us to study the specific role of both, prediabetes and T2D, in the development of AD pathology, including generation of Aβ species or brain atrophy, as well as specific neuronal alterations such as axonal curvature and synaptic loss. Together, our data suggest that early hyperinsulinemia is sufficient to exacerbate central pathology in APP/PS1 mice, and that this effect further worsens when T2D diabetes is completely established.
Methods Animals
APPswe/PS1dE9 mice were obtained from the Jackson Laboratory (Bar Harbor, USA) [22, 23] . Prediabetes was induced in wild type and APP/PS1 mice as previously described [24] by feeding them HFD (60 % Kcal from fat, OpenSource, USA) from 4 weeks of age until sacrifice at 26-27 weeks of age. Wild type and APP/PS1 mice received regular diet (RD) (SAFE A04. Augy, France).
To compare the effects of prediabetes and diabetes on brain pathology, APP/PS1 mice were crossed with db/db mice (Harlan Laboratories, The Netherlands) [19] . In order to characterize the effect of type 2 diabetes on AD pathology, [26] [27] 
Metabolic Determinations
Body weight, postprandial blood glucose, and plasma insulin levels were determined immediately before sacrifice in all groups, as previously described [24] . Blood glucose levels were measured from nicked tails using the glucometer Optium Xceed (Abbott, UK). Plasma insulin levels were measured using ultrasensitive mouse enzyme-linked immunoabsorbent assay (ALPCO Diagnostics, Salem, NH).
Tissue Processing
At 26-27 weeks of age, animals were overdosed with chloral hydrate (60 mg/Kg). Brains were harvested and immediately weighed. Cortical tissue was dissected from the right hemisphere and stored at −80°C prior to use. A small portion of the sensorimotor cortex (∼1 mm 3 ) was also dissected for array tomography studies and fixed as previously described [25] . Left hemispheres were fixed in 4 % paraformaldehyde (PFA) for 2 weeks before 30 μm coronal brain sections were obtained using a Microm HM450 microtome (ThermoFisher, Spain) and stored in 50 % polyethyleneglycol at 4°C.
Cresyl Violet Staining
Sections were selected at 1.5, 0.5, −0.5, −1.5, −2.5, and −3.5 mm from Bregma [26] , as previously described [24] , in order to analyze the cortex from all mice groups. Sections were mounted with DPX (Sigma, St. Louis, MO, USA), and images were acquired using an optical Laser Olympus U-RFL-T microscope (Olympus, Japan) and MMIcellTools software. Cortical thickness was measured in the frontal, parietal, and temporal cortical sections using Adobe Photoshop Elements and Image J software.
Caspase Activation
Caspases 3/7 activity was analyzed in cortical homogenates from all groups in this study using the Caspase-Glo 3/7 assay (Promega, Madrid, Spain), following manufacturer's indications. Briefly, 5-7 mg of cortex was homogenized in PBS supplemented with a protease cocktail (Sigma, USA). Samples were diluted with PBS (2 μg/μl), and 50 μl of tissue homogenate was added to 50 μl of Promega Caspase-Glo 3/7 assay solution. Samples were incubated 1 h at room temperature, protected from light. Luminescence signal was measured in the Biotek Synergy Mx Microplate Reader, and data were expressed as percentage of control values.
Senile Plaque Quantification
Cortical Aβ burden was quantified in consecutive sections to those used for cresyl violet staining as previously described [27] . Sections were incubated with anti-Aβ antibody 1:2000 (AB2287 Millipore, USA) in 0.5 % BSA overnight at 4°C. Secondary antibody, donkey anti-rabbit Alexa Fluor 594 (Molecular Probes, OR, USA) 1:1000, in 0.5 % BSA, was incubated for 1 h at room temperature. Tissue was incubated with thioflavin-S (TS) 0.005 % (Sigma, USA) 10 min at room temperature for dense core SP. Sections were visualized with a laser Olympus U-RFL-T fluorescent microscope (Olympus, Japan). Images were acquired using MMIcellTools software and analyzed with Image J software to quantify Aβ and TS burdens. 
Aβ40 and Aβ42 levels

NeuN and DAPI staining
PFA-fixed 30 μm sections were washed in PBS, pretreated with 70 % formic acid for 10 min and subsequently blocked in 5 % normal goat serum (NGS) and 0.5 % Triton-X100 for 1 h. Sections were immunostained with anti-NeuN antibody (Chemicon) 1:200 as previously described [29] , and conjugated goat anti-mouse Alexa Fluor 594 was used as secondary antibody. Sections were washed and stained with 4′,6-diamidino-2-phenylindole (DAPI) 1 mg/ml (Sigma) (1:2000) to stain nuclei and TS (0.005 %) to visualize SP. The percentage of NeuN-possitive cells (normalized by total cells stained with DAPI was quantified in the proximity of SP in APP/PS1, APP/PS1-HFD, and APP/PS1xdb/db mice (up to 40 μm). Areas located far from SP were also compared with control, control-HFD, and db/db mice using Image J software.
Axonal Immunostaining
Axonal curvature was determined by immunostaining with SMI-312R antibody (1:1000) (Covance, USA) on consecutive sections to those used for cresyl violet staining. Briefly, sections were pretreated with hydrogen peroxide 3 % and Triton-X 0.5 % 20 min at room temperature and blocked with 3 % BSA 1 h. Alexa Fluor goat anti-mouse 594 was used as secondary antibody (Molecular Probes, USA) 1:200, in 1 % NGS for 1 h at room temperature. SP were visualized by staining with thioflavin S (TS) (0.005 % w/v). Micrographs of stained tissue were obtained with a Laser Olympus U-RFL-T fluorescent microscope (Olympus, Japan) and MMIcellTools software. Axon curvature ratio was calculated by dividing the end-to-end distance of a dendrite segment by the total length between the two segment ends. Axon distance to the closest SP was measured at three points along each dendrite, and the average distance was taken from these three measurements [30] . Axon curvature ratio and distance to SP were measured using Image J software. Curvatures were pooled in 10 μm steps from SP up to 40 μm from the border, and neurites analyzed further from SP borders were considered in SP-free areas. In SP-free animals, axon curvature was compared with those measured in APP/PS1 mice further than 40 μm from SP.
Array Tomography
Array tomography in combination with immunohistochemistry is a powerful approach to assess synaptic density in small tissue blocks. Synaptic density was assessed in 26-27 week old mice. Tissue from all groups under study was prepared for array tomography as previously described [25] . Briefly, cortical samples were fixed in 4 % PFA for 4 h, dehydrated through increasing serial dilutions of ethanol and immersed into LR White resin (Electron Microscopy Sciences) to polymerize overnight at 53°C. Embedded blocks were cut into ribbons (70 nm) by ultracut microtome (Leica) using a jumbo histo diamond knife (Diatome). Sections were rehydrated for 5 min with 50 mM glycine in TBS and blocked 5 min in 0.05 % Tween and 0.1 % BSA. Primary antibodies for PSD95 (Abcam, USA) and 6E10 for Aβ (Covance, USA) were incubated (1:50) in blocking buffer overnight at 4°C. Secondary antibodies (Jackson ImmunoResearch, USA) were incubated at 1:50 in blocking buffer for 30 min. Sections were counterstained with 0.01 mg/mL DAPI for 20 min. For each area of interest (identified by fiduciary markers, such as nuclei), images were obtained on 18-25 serial sections through the somatosensory cortex using a Zeiss AxioImager Z2 microscope (Zeiss, Germany). Each set of images were opened sequentially in Image J, aligned, and processed in Watershed software (courtesy of Brad Busse and Steven Smith) to detect puncta larger than 10 voxels in volume that were present in more than one consecutive section. Synapse densities were calculated by dividing the number of PSD95-positive puncta by the volume of tissue sampled. The combined role of SP Bhalo effect^and metabolic alterations on synaptic density was assessed up to 40 μm from plaque borders (in 10 μm steps) in SP-bearing groups. The number of PSD95 dots in SP-free mice was compared with APP/PS1 mice densities when distance from SP were >40 μm.
Statistical Analysis
Control groups from prediabetic (wild type-RD) and T2D (APP/PS1 +/+ db/db +/+ and APP/PS1
) studies were compared and no differences were observed. Therefore, all animals were included as a single control group. Two-way ANOVA (group X distance from SP) was used to compare synaptic density and axonal curvature. Further analyses by one-way ANOVA for independent samples were performed for individual distance subsets studied. One-way ANOVA was used to compare metabolic parameters, Aβ levels, caspase activation, and cortical thickness. Correlation studies were performed using Pearson's correlation test.
Results
Metabolic Characterization
Body weight was significantly increased in both control and APP/PS1 mice on HFD for 23 weeks (Table 1) , and this effect was higher in T2D mice, both db/db, and APP/PS1xdb/db. Although a slight increase in glucose levels was observed in APP/PS1-HFD treated mice, differences did not reach statistical significance and were below 300 mg/dl, as a control limit for diabetes [24] . Conversely, T2D mice showed a significant increase in glucose levels, clearly over 300 mg/dl, when db/db and APP/PS1xdb/db mice were compared (Table 1) . Plasmatic insulin was significantly increased in control-HFD mice, and even higher values were detected in APP/PS1-HFD mice (Table 1) , supporting long-term HFD as a model of hyperinsulinemia and prediabetes [24] . When we analyzed diabetic mice, we also observed a significant increase in insulin levels in db/db and a slightly higher, non significant increase was also detected in APP/PS1xdb/db mice (Table 1) .
T2D Induced Atrophy is Worsened in AD-T2D Mixed Model
A slight, non significant, reduction in brain weight was observed in APP/PS1-HFD mice. As previously reported, a significant reduction of brain weight was observed in db/db mice [24] . Brain weight reduction was maximal in APP/PS1xdb/db mice, suggesting a stepwise worsening effect from prediabetes to diabetes, and supporting a synergistic interaction between the presence of APP/PS1 transgenes and db/db-induced metabolic alterations [20] (Fig. 1a) . In accordance with macroscopic observations, we detected a reduction of cortical thickness in db/db mice [31] that was further exacerbated in APP/ PS1xdb/db mice (Fig. 1b, c) .
Caspase Activation and Neuronal Loss is Progressively Increased in AD-Prediabetic and Diabetic Mice
Caspases 3/7 activation was similar to controls in the cortex from APP/PS1 and APP/PS1-HFD mice. However, we detected a significant increase in activation of cortical caspases 3/7 in db/db mice. This effect was further increased in APP/ PS1xdb/db mice (Fig. 2a) . The specific effect of the atrophy and cell death, on neurons was also assessed. In SP-free areas, the percentage NeuN-positive cells were slightly reduced in APP/PS1-HFD mice, and this effect was worsened in db/db mice. Moreover, in APPP/PS1xdb/db mice neuronal loss was increased when compared with the rest of the groups (Fig. 2b,  c) . In the close proximity of SP, a relevant reduction in the NeuN+/DAPI ratio was detected in all groups (APP/PS1, APP/PS1-HFD, and APP/PS1xdbdb) when compared with SP-free areas; however even higher reductions were observed in the mixed model, APP/PS1xdb/db also in the proximity of the plaques (Fig. 2b, c) .
Altered Aβ Pathology in Prediabetic and Diabetic APP/PS1 Mice
As previously shown, prediabetes and diabetes do not necessarily affect amyloid pathology in the same manner [19] [20] [21] 32] . We observed an overall increase of SP in prediabetic APP/PS1 mice after long-term HFD, whereas a reduction in dense-core plaques stained with TS was observed in the mixed Insulin levels were increased in HFD treated mice, and higher levels were detected in T2D mice. Although statistical differences were not detected, hyperinsulinemia was more severe in APP/PS1xdb/db mice [F (5,45) = 9.5, **p < 0.01 vs. rest of the groups, † †p < 0.01 vs. control and APP/PS1 groups] In the proximity of SP, reduced NeuN+/DAPI ratios were observed when compared to SP-free areas, and this effect was worsened in APP/PS1xdb/ db mice [F (2371) = 7.53, **p < 0.01 vs. rest of the groups]. c Representative images of NeuN+/DAPI ratios in all groups under study (NeuN-red, DAPI-blue, thioflavin S-green). Scale bar = 25 μm T2D-AD animal model (APP/PS1xdb/db) [19, 21] (Fig. 3a, b) . We corroborated these findings by measuring Aβ by ELISA, and we detected increased insoluble Aβ40 levels in prediabetic APP/PS1 mice (Fig. 3c) . Treatment of APP/PS1 mice with HFD increased soluble Aβ40 and 42 levels, following a similar trend previously reported [20, 32] , although differences only reached statistical significance in APP/PS1xdb/db mice, both for Aβ40 and 42 cortical levels (Fig. 3c) . As previously suggested, our data support a shift towards more toxic soluble species in our mixed APP/PS1xdb/db model.
Diabetes Worsens AD Neurite Curvature
We analyzed neurite curvature as an indication of neuronal dysfunction [33] [34] [35] , in the proximity of SPbearing groups (APP/PS1, APP/PS1-HFD, and APP/ PS1xdb/db). We also compared neurite curvature in SP-free groups (control, control-HFD, and db/db) and in SP-free areas from all APP/PS1 groups. Neurite curvature was not affected in control-HFD mice whereas a slight increase in neurite curvature was observed both in APP/PS1 and APP/PS1-HFD mice even in SP-free areas. This effect was more severe in db/db mice, suggesting that neuronal integration is impaired in a T2D animal model. Furthermore, curvature ratios in SP-free areas were significantly worsened in APP/PS1xdb/db mice when compared to the rest of the groups, supporting a cross-talk between both pathologies (Fig. 4a, b) . Brain regions containing SP (APP/PS1, APP/PS1-HFD and APP/PS1xdb/db mice) presented increased curvature ratios, when compared to SP-free areas and mice without SP. This effect was worsened in animals harboring both T2D and AD (APP/PS1xdb/ db) (Fig. 4a, b) . In plaque-bearing mice (APP/PS1, APP/PS1-HFD, and APP/PS1xdb/db), we also analyzed the Bhalo^effect of SP on neurite curvature, by allocating measured neurons in 10 μm intervals from plaque border up to 40 μm. As expected, curvature ratio increased as distance to plaques was reduced, and we detected a group X distance effect when we compared among groups [F (8, (Fig. 4c) .
Amyloid-Plaque Induced Synaptic Loss is Increased in Diabetic Mice
Synaptic density was reduced in APP/PS1 mice even far from SP. Interestingly, even in the absence of amyloid pathology, we also detected that db/db mice presented reduced synaptic densities, indicating that T2D alone can significantly impair synapses (Fig. 5a, c) . A significant reduction in synaptic density was detected in the close proximity of SP. This reduction was approximately 30 % in APP/PS1 mice, compared to control mice, in the range of previous observations [25] and up to 50 % reduction in APP/PS1xdb/db mice, supporting the synergistic effect between AD and T2D also on synaptic dysfunction (Fig. 5a, c) . Analysis also revealed a Bhalo^effect around SP, in agreement with previous work [25] . We did not detect a group X distance effect in synaptic density [F (8, 1027) = 0.99, p = 0.440]; however, further analysis of individual subsets revealed an overall exacerbation of synaptic loss in APP/PS1xdb/db mice (Fig. 5b, c) . Soluble Aβ40 and 42 levels negatively correlated with synaptic densities, reaching statistical significance far from SP (Pearson's correlations: Aβ40-synaptic density (p = −0.664**) and β42 -synaptic density (p = −0.599**, **p < 0.01). The fact that plaqueinduced synaptic toxicity was increased in APP/PS1xdb/db mice, and that synaptic density was still compromised far from SP (>40 μm) in this group, supports a synergistic effect between amyloid pathology and metabolic alterations associated with T2D. Fig. 4 Neurite curvature was increased in APP/PS1-HFD mice, and this effect was worsened in APP/PS1xdb/db mice. a Curvature ratios were slightly increased in APP/PS1 in SP-free areas when compared with control groups. Also, neurite curvature was significantly increased in db/db mice, and this effect was worsened in APP/PS1xdb/db mice when we compared SP-free areas in all groups under study. Data are representative of five mice, and differences were detected by one-way ANOVA followed by Tamhane observed in db/db mice when compared with control mice. SP-bearing mice also show a higher neurite curvature ratio, and this effect is increased in APP/PS1xdb/db mice. Scale bar = 20 μm. c Curvature ratios were reduced with increased distances to SP, when plotted in 10 μm subsets, in plaque-bearing groups. We observed a distance X group effect, and further assessment of individual subsets revealed that APP/PS1xdb/db mice presented a significantly higher curvature ratio than APP/PS1 and APP/PS1-HFD mice, whereas prediabetic APP/PS1 mice were similar to other groups. Differences were detected by one-way ANOVA for independent samples, followed by 
Discussion
Previous epidemiological and preclinical studies support a close relationship between AD and T2D (for review see [10, 17] ; however, the underlying mechanisms are not completely understood. It also remains unclear whether hyperinsulinemia and insulin resistance, indicative of a prediabetic state prior to T2D, may also induce or accelerate central pathology in AD. Indeed, glucose and insulin play a crucial role in maintaining normal brain activity, and alterations of insulin dependent functions could be associated with central pathological conditions observed in AD [10, 15, 16, 20, 24] . In order to address the role of T2D and prediabetes on neuronal and synaptic alterations in AD, we induced a severe hyperinsulinemia by long-term HFD administration to APP/PS1 mice. We also used a mixed animal model that presents both T2D and AD (APP/PS1xdb/db mouse) [19] . All animals under study were analyzed at 26-27 weeks of age, when SP deposition has commenced in APP/PS1 mice [23] , and prediabetes or diabetes has been completely established. Only T2D mice (db/db and APP/PS1xdb/db) presented glycaemia levels over 300 mg/dl, which is considered the threshold for a diagnosis of diabetes in rodents [20, 36] . HFD induced high insulin levels, and this effect was worsened when diabetes was completely established. Prediabetic mice overweight increased in diabetic mice (both db/db and APP/PS1xdb/db). Altogether, metabolic parameters indicate a progressive worsening effect from prediabetes to completely established T2D. Neuronal and synaptic losses are major hallmarks of AD, and brain atrophy is observed in both AD and T2D patients; however, one of the main limitations of present AD mouse models is that they show very little neuronal loss [37] . Diabetic (db/db) mice showed a significant reduction in brain weight, as previously described [24] , and this effect was worsened in combination of APP/PS1 transgenes, suggesting that aggravated brain atrophy in APP/PS1xdb/db mice is due to a synergic effect between AD and T2D. Also, cortical atrophy was observed in AD-T2D mice, which is in line with previous observations in T2D patients, who have diminished brain volume and cortical grey matter [38, 39] . Increased apoptosis in the APP/PS1xdb/db mice may be due to higher caspase activity. Indeed, we observed increases in caspase 3 and 7 in db/db mice, and even higher activity in APP/PS1xdb/db mice. Although caspase activation cannot unequivocally determine cell apoptosis, it may contribute to synapse loss which ultimately causes deafferentation and cell death [40] . Moreover, NeuN/DAPI ratios were progressively reduced in prediabetic APP/PS mice, db/db, and APP/PS1xdb/db mice, supporting a worsening prediabetes to diabetes effect. Reduced neuronal density might be due to increased gliosis, observed both in APP/PS1 and db/db animals [19] . However, our data in combination with previous studies, in which central proliferation and neurogenesis processes seem to slow with aging in db/db mice [31] , might further underscore the mechanisms of the neurodegeneration which evolves in the mixed colony (APP/ PS1xdb/db). Leptin signalling is involved in synaptic function, neurodegeneration or learning, and memory formation [41, 42] , and therefore, our observations might not exclusively be due to diabetes. However, our AD-prone prediabetic model (APP/PS1-HFD) showed a small reduction in brain weight, cortical thickness, and neuronal population, suggesting the possibility of an intermediate state, before T2D onset, that could reveal some early prediabetes-related loss of neuronal integrity.
Whereas peripheral neuropathy has been widely addressed in T2D, central neuronal pathology associated is not so well characterized. It has been previously stated that, just as any other insulin-dependent metabolically active tissue, neurons also develop insulin resistance and cannot respond to insulin, resulting in neuronal injury (for review see [43] ). In order to further characterize the observed brain atrophy in our mixed model of T2D and AD, we examined neurite curvature, as an indicator of abnormal neuronal morphology correlated with neuronal dysfunction (Stern et al. 2004 ). In AD mice, SP plaques can distort neurites in the close proximity, and a Bhaloê ffect of neurite pathology is clearly observed surrounding the plaques [35] . Whereas this effect has been largely addressed in AD models, to our knowledge, no previous assessment of central axon curvature has been performed in db/db mice. We observed that even in the absence of plaques, T2D in db/db mice is sufficient to distort neuronal curvature, suggesting that synaptic transmission is also dysfunctional [44] . As expected, the presence of plaques in APP/PS1 mice caused an increase of axonal curvature, that was worsened in the proximity of the plaques. Comparison of SP-bearing transgenic mouse groups showed that prediabetic mice (APP/PS1-HFD) had a more robust Bhalo^effect on abnormal curvature, which again suggests an intermediate state in case of prediabetic mice. Abnormal neurite curvature was further exacerbated in APP/ PS1xdb/db mice. Since T2D is a metabolic disorder that also provokes micro and macrovascular complications, inflammation, and increased oxidative stress [17] , several mechanisms may be responsible for increased neuritic curvature in the combined T2D-AD mouse line (APP/PS1xdb/db), as previously observed in other AD models [30, 34, 35] . While we did not perform behavioral studies, it has been previously shown that both prediabetes and diabetes-induced states in APP/PS1 mice significantly impair learning and memory abilities [19, 20] . Moreover, metabolic alterations significantly correlate with central pathology in both models, supporting the role of metabolic alterations at central level.
We also analyzed synaptic density by array tomography, allowing the study a great amount of synapses [25] , represented by PSD95-positive synaptic puncta. We observed a similar profile to that detected for neurite curvature, with db/db mice displaying significant reduction of synaptic density, supporting the neurotoxic effect of T2D on the brain. Extensive evidence shows that Aβ in different states of aggregation, ranging from soluble species to dense core plaques, are neurotoxic [25, 35, 45] . Prediabetic AD mice presented an intermediate state, displaying some synaptic loss. However, the largest reduction in synaptic density was observed in APP/PS1xdb/db mice, and synapse loss is the strongest correlate of cognitive decline in AD [1] . It has been previously shown that the space occupied by SP dense core results in almost a total loss of synapses [25] , and we also observed that the striking reduction in PSD95-positive puncta in the close proximity of the plaques, which has been shown to coincide with a Bhalo^of oligomeric Aβ surrounding the plaques [25] and was worsened in APP/PS1xdb/db mice. These observations are also in agreement with detected soluble Aβ levels: increased soluble Aβ40 and 42 levels were measured in APP/PS1-HFD mice, which were even higher in APP/ PS1xdb/db mice [19] [20] [21] . On the other hand, SP burden was reduced in APP/PS1xdb/db mice, as previously described in this animal model [19, 46] . We cannot exclude that Aβ might be preferentially depositing as amyloid angiopathy in leptomeningeal vessels, instead of SP, in APP/PS1xdb/db mice. Our data might be in accordance with recent hypothesis on amyloid-dependent and amyloid-independent stages of AD, with an initial phase mediated by soluble oligomeric and fibrilar Aβ accumulation that leads to disruption of the neuropil, loss of dendritic spines, remodeling of neurites, and inflammatory responses, followed by a second phase that would consist of the further development of tangles, and synaptic and neuronal loss [12] . It is feasible that the observed increase in toxic soluble species [47] might contribute to progressive synapse reduction in prediabetic and diabetic AD mice. The combination of AD with T2D may therefore shift Aβ pathology towards a more severe version of the disease, which ultimately contributes to abnormal axonal curvature and synaptic loss.
Our data support a synergy between T2D and AD [19, 20] . AD brain pathology was initially exacerbated in prediabetes and significantly worsened after diabetes was fully established. These data support the potential use of insulin resistance therapies and a tight metabolic control in diabetic patients, to prevent or delay associated central complications, including AD. Interestingly, our data on prediabetes suggests that, since this is still a reversible metabolic state, brain associated alterations could also be potentially reversible with good metabolic control, stressing the relevance of an early detection and management of insulin resistance.
